(PharmaNewsWire.Com, April 20, 2017 ) Market Data Forecast published a syndicated report on the Latin America Diabetic Retinopathy Market which estimates the market to reach USD 1.15 billion from USD 0.79 billion in 2016 with a high CAGR of 7.69%.
Diabetes is the long-lasting condition associated with unusually high level of glucose in the blood. Non-production or deficient of insulin in pancreas causes diabetes. Diabetic retinopathy is the most normal complication of diabetic that affects eyes. People suffering from diabetes type I and II have threat of developing diabetic retinopathy. Leakage or swelling of blood vessels of retina is the causes of the disease.
Various key factors which drive the market towards growth or restrain the market by downsizing the value are covered in the DROC analysis. Some of those key factors are growing geriatric population base, rising occurrences of diabetes and the increasing demand for early detection. Furthermore, increasing demand for cost-effective, refining healthcare infrastructure and safe treatment and rising focus of market players on developing regions are also estimated to propel market growth.
The products are segmented based on Type of Treatment, Indication and End Users and studied for a deep-level understanding of the Diabetic Retinopathy Market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Based on Product: Introduction Feed Additives Pharmaceuticals Vaccines Y-o-Y Growth Analysis, By Product Market Attractiveness Analysis, By Product Market Share Analysis, By Product
Geographically the Latin America Diabetic Retinopathy Market is analysed under the regions of Mexico, Brazil, and Argentina. Latin America is projected to display profitable growth in the forecast period. Favourable clinical guidelines and government initiatives are anticipated to increase the treatment and diagnosis rate, thereby fuelling the growth of the market in the region.
As per the report, companies like Bayer AG, Hoffmann-La Roche ltd, Pfizer Inc., Novartis AG, Valeant Pharmaceutical International Inc., Regeneron Pharmaceutical Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.
Further, equipment like utilization of slit lamps and launching of new products like Gly-230 & Optima and technological breakthroughs in retinal screening methods are the factors estimated to drive the industry enlargement. Increasing occurrence of diabetes predicted to affect more than 4.6% of world population will also improve the industry growth.
Scope of the Latin America Diabetic Retinopathy Market:
• Regional and country-level analysis that provides an intrinsic perspective of Brazil, Argentina and Mexico markets to that of the Latin American region
• Segment-level analysis on basis of Type of Treatment, Indication and End Users along with market size forecasts and y-o-y estimations are provided for better understanding of major focus areas
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Macro & Micro environmental factors such as political influence, legal barriers, technological prowess and industry rivalry are covered in the extensive PESTLE and Porter’s Five Forces Analyses.
• Comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
• Mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
• Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
About Market Data Forecast: Market Data Forecast is one of the prominent market research companies which offers syndicated as well as customized research services to individual or corporate clients. Their syndicated research reports contain Market Sizing and forecasts for 5-year period with a niche level of segmentation providing you with more focused insights whereas the consult research services can fetch the distinctive data requirements at competitive industry costs. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
